Back to basics as I break down a trialBy Plenary Session

I discuss RFK Jr.'s confirmation as the US Secretary of Health and Human Services; recent layoffs at the CDC and NIH; and some comments by Harold Varmus in criticism of Jay Bhattacharya.By Plenary Session

I discuss the recent reduction in indirect funds for NIH grants and lay out why the NIH is a broken funding system.By Plenary Session

I discuss the CIA admitting that COVID was a lab leak; Fauci's pardon; NIH meetings; RFK Jr's Senate confirmation hearing; and more.By Plenary Session

I discuss the intense media coverage of Trump and the recent decision to cap indirect costs of NIH grants at 15%.By Plenary Session

I'm talking about USAID and Elon's team of six engineers; the Bobby Kennedy Jr hearings, particularly concerning Samoa; MMR vaccines; DEI; and NIH funding complaints.By Plenary Session

I discuss Trump's big health care changes: NIH study sections, the MMWR gag order, the US withdrawal from WHO, and more!By Plenary Session

The entire healthcare system is broken, it's not just health insurance companies.By Plenary Session

Is alcohol healthy for you? I break down everything you need to know about beer, wine, and spirits.By Plenary Session

Our 2 hour critical appraisal and ASH review. SO many guest starsBy Plenary Session

Lecture on systematic review, given by Vinay Prasad MD MPH to students in the UCSF Training in Clinical Research Program, November 2024.By Plenary Session

Timothee Olivier and I discuss the top ESMO 2024 abstracts!By Plenary Session

AI in healthcare - my latest keynote addressBy Plenary Session

"Masking Mistakes: Lessons from the Science, Policy, and Coverage of COVID-19", the 2024 Brian Shields Lecture on Institutional Ethics which took place on Monday, October 7, 2024 for the Emory Center for Ethics. A conversation with Carlos Del Rio, MD and Vinay Prasad, MD MPH with moderation by Gerard Vong, DPhil, Director of the MA in Bioethics pro…

Screening/ Drug efficacy/ Sotorasib/ Adaura and moreBy Plenary Session

My UCSF lecture on driver mutation lung cancerBy Plenary Session

We break down the best studies from ASCOBy Plenary Session